Term Name:	molnupiravir
Synonyms:	beta-D-N(4)-hydroxycytidine-5'-isopropyl ester, EIDD 1931 5'-isopropylester, EIDD 2801, EIDD-2801, MK-4482, molnupiravir, molnupiravirum, N(4)-hydroxycytidine 5'-isopropylester, N-hydroxy-5'-O-(2-methylpropanoyl)-3,4-dihydrocytidine, {(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl]tetrahydrofuran-2-yl}methyl 2-methylpropanoate
Definition:	A nucleoside analogue that is N(4)-hydroxycytidine in which the 5'-hydroxy group is replaced by a (2-methylpropanoyl)oxy group. It is the prodrug of the active antiviral ribonucleoside analog N(4)-hydroxycytidine (EIDD-1931), has activity against a number of RNA viruses including SARS-CoV-2, MERS-CoV, and seasonal and pandemic influenza viruses. It is currently in phase III trials for the treatment of patients with COVID-19.
Ontology:	ChEBI [CHEBI:180653]  ( EBI )